Filed Pursuant to Rule 433 under the Securities Act of 1933
Registration Statement No. 333-188918
Issuer Free Writing Prospectus, dated August 8, 2013
Boston Scientific Corporation
$1,050,000,000
Senior Notes Offering
Terms and Conditions — 5 and 10 Year Fixed Rate Notes
|
|
|
5-Year |
|
10-Year |
|
Issuer |
|
Boston Scientific Corporation |
|
Boston Scientific Corporation |
|
Note Type |
|
Senior Notes |
|
Senior Notes |
|
Form of Offering |
|
SEC Registered |
|
SEC Registered |
|
Ratings (1) |
|
Baa3 Moody’s BBB- S&P BBB- Fitch |
|
Baa3 Moody’s BBB- S&P BBB- Fitch |
|
Principal Amount |
|
$600,000,000 |
|
$450,000,000 |
|
Trade Date |
|
August 8, 2013 |
|
August 8, 2013 |
|
Settlement Date (T+3) |
|
August 13, 2013 |
|
August 13, 2013 |
|
Maturity Date |
|
October 1, 2018 |
|
October 1, 2023 |
|
Coupon |
|
2.650% per annum |
|
4.125% per annum |
|
Yield to Maturity |
|
2.659% per annum |
|
4.132% per annum |
|
Price to Public |
|
99.954% |
|
99.936% |
|
Spread to Benchmark Treasury |
|
Plus 130 basis points |
|
Plus 155 basis points |
|
Benchmark Treasury |
|
1.375% UST due July 31, 2018 |
|
1.750% UST due May 15, 2023 |
|
Benchmark Treasury Yield |
|
1.359% |
|
2.582% |
|
Interest Payment Dates |
|
Semi-annually on April 1 and October 1 |
|
Semi-annually on April 1 and October 1 |
|
First Interest Payment Date |
|
April 1, 2014 |
|
April 1, 2014 |
|
Optional Redemption |
|
Plus 20 basis points |
|
Plus 25 basis points |
|
Optional Par Call |
|
N/A |
|
Commencing on July 1, 2023 at 100% |
|
Day Count Basis |
|
30/360 |
|
30/360 |
|
Minimum Denominations |
|
US $2,000 and integral multiples of US $1,000 in excess of such amount |
|
US $2,000 and integral multiples of US $1,000 in excess of such amount |
|
CUSIP / ISIN |
|
101137 AM9/US101137AM97 |
|
101137 AN7/US101137AN70 |
|
Joint Bookrunners |
|
Barclays Capital Inc. J.P. Morgan Securities LLC Merrill Lynch, Pierce, Fenner & Smith Incorporated BNP Paribas Securities Corp. Citigroup Global Markets Inc. Deutsche Bank Securities Inc. RBC Capital Markets, LLC RBS Securities Inc. UBS Securities LLC |
|
Barclays Capital Inc. J.P. Morgan Securities LLC Merrill Lynch, Pierce, Fenner & Smith Incorporated BNP Paribas Securities Corp. Citigroup Global Markets Inc. Deutsche Bank Securities Inc. RBC Capital Markets, LLC RBS Securities Inc. UBS Securities LLC |
|
Co-Managers |
|
SMBC Nikko Securities America, Inc. Banca IMI S.p.A. DNB Markets, Inc. HSBC Securities (USA) Inc. Scotia Capital (USA) Inc. Standard Chartered Bank US Bancorp Investments, Inc. Wells Fargo Securities, LLC |
|
SMBC Nikko Securities America, Inc. Banca IMI S.p.A. DNB Markets, Inc. HSBC Securities (USA) Inc. Scotia Capital (USA) Inc. Standard Chartered Bank US Bancorp Investments, Inc. Wells Fargo Securities, LLC |
Notes:
(1) A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
THE ISSUER HAS FILED A REGISTRATION STATEMENT (INCLUDING A PROSPECTUS) WITH THE SEC FOR THE OFFERING TO WHICH THIS COMMUNICATION RELATES. BEFORE YOU INVEST, YOU SHOULD READ THE PROSPECTUS IN THAT REGISTRATION STATEMENT AND OTHER DOCUMENTS THE ISSUER HAS FILED WITH THE SEC FOR MORE COMPLETE INFORMATION ABOUT THE ISSUER AND THIS OFFERING. YOU MAY GET THESE DOCUMENTS FOR FREE BY VISITING EDGAR ON THE SEC WEB SITE AT WWW.SEC.GOV. ALTERNATIVELY, THE ISSUER, ANY UNDERWRITER OR ANY DEALER PARTICIPATING IN THE OFFERING WILL ARRANGE TO SEND YOU THE PROSPECTUS IF YOU REQUEST IT BY CALLING BARCLAYS CAPITAL INC. TOLL-FREE AT (888) 603-5847, J.P. MORGAN SECURITIES LLC COLLECT AT (212) 834-4533 OR MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED TOLL-FREE AT (800) 294-1322.
ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.